Literature DB >> 12663765

Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2.

Teresa Compton1, Evelyn A Kurt-Jones, Karl W Boehme, John Belko, Eicke Latz, Douglas T Golenbock, Robert W Finberg.   

Abstract

Human cytomegalovirus (CMV) is a ubiquitous opportunistic pathogen that causes significant morbidity and mortality in immunocompromised people. An understanding of how CMV induces and circumvents host immunity is of critical importance in efforts to design effective therapeutics. It was recently discovered that mere cell contact by CMV particles leads to profound modulation of cellular gene expression, including induction of inflammatory cytokines and interferon-stimulated genes characteristic of innate immune detection. These findings suggest that a membrane receptor recognizes a CMV envelope protein(s), leading to innate immune activation. Here, we show that the pattern recognition receptors Toll-like receptor 2 (TLR2) and CD14 recognize CMV virions and trigger inflammatory cytokine production. Induction of inflammatory cytokines is mediated via TLR2-dependent activation of NF-kappa B. Since many of the pathological processes associated with CMV disease are facilitated or directly mediated by inflammatory cytokines, identification of the host membrane detection machinery may ultimately lead to improved therapeutics.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663765      PMCID: PMC152130          DOI: 10.1128/jvi.77.8.4588-4596.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

Review 1.  Viral subversion of the immune system.

Authors:  D Tortorella; B E Gewurz; M H Furman; D J Schust; H L Ploegh
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Human cytomegalovirus blocks interferon-gamma stimulated up-regulation of major histocompatibility complex class I expression and the class I antigen processing machinery.

Authors:  D M Miller; Y Zhang; B M Rahill; K Kazor; S Rofagha; J J Eckel; D D Sedmak
Journal:  Transplantation       Date:  2000-02-27       Impact factor: 4.939

Review 3.  Human cytomegalovirus latency and reactivation - a delicate balance between the virus and its host's immune system.

Authors:  C Söderberg-Nauclér; J Y Nelson
Journal:  Intervirology       Date:  1999       Impact factor: 1.763

Review 4.  Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus.

Authors:  E A Fortunato; A K McElroy; I Sanchez; D H Spector
Journal:  Trends Microbiol       Date:  2000-03       Impact factor: 17.079

5.  Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2.

Authors:  M Hirschfeld; Y Ma; J H Weis; S N Vogel; J J Weis
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

6.  p38-dependent activation of interferon regulatory factor 3 by lipopolysaccharide.

Authors:  L Navarro; M David
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

7.  Widespread presence of histologically occult cytomegalovirus.

Authors:  D Myerson; R C Hackman; J A Nelson; D C Ward; J K McDougall
Journal:  Hum Pathol       Date:  1984-05       Impact factor: 3.466

8.  Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

Authors:  P Tomasec; V M Braud; C Rickards; M B Powell; B P McSharry; S Gadola; V Cerundolo; L K Borysiewicz; A J McMichael; G W Wilkinson
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

9.  Hydrolysis of inositol lipids: an early signal of human cytomegalovirus infection.

Authors:  T Valyi-Nagy; Z Bandi; I Boldogh; T Albrecht
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

Review 10.  Viral mechanisms of immune evasion.

Authors:  A Alcami; U H Koszinowski
Journal:  Trends Microbiol       Date:  2000-09       Impact factor: 17.079

View more
  257 in total

1.  Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity.

Authors:  Lenore Pereira; Ekaterina Maidji; Susan McDonagh; Olga Genbacev; Susan Fisher
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  Receptor "cross talk" in innate immunity.

Authors:  Eicke Latz; Douglas T Golenbock
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

Review 3.  Herpes simplex virus virion host shutoff protein: immune evasion mediated by a viral RNase?

Authors:  James R Smiley
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 4.  Innate sensing of viruses by toll-like receptors.

Authors:  Karl W Boehme; Teresa Compton
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

5.  Role of the proximal enhancer of the major immediate-early promoter in human cytomegalovirus replication.

Authors:  Hiroki Isomura; Tatsuya Tsurumi; Mark F Stinski
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

6.  Human cytomegalovirus-specific CD4+-T-cell cytokine response induces fractalkine in endothelial cells.

Authors:  Cynthia A Bolovan-Fritts; Rodney N Trout; Stephen A Spector
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 7.  Accessory molecules for Toll-like receptors and their function.

Authors:  Clarissa C Lee; Ana M Avalos; Hidde L Ploegh
Journal:  Nat Rev Immunol       Date:  2012-02-03       Impact factor: 53.106

Review 8.  Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9.

Authors:  Tomoki Ito; Yui-Hsi Wang; Yong-Jun Liu
Journal:  Springer Semin Immunopathol       Date:  2004-11-13

9.  Characterization of human cytomegalovirus glycoprotein-induced cell-cell fusion.

Authors:  Eric R Kinzler; Teresa Compton
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

10.  Human cytomegalovirus inhibits differentiation of monocytes into dendritic cells with the consequence of depressed immunological functions.

Authors:  Sara Gredmark; Cecilia Söderberg-Nauclér
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.